-
Exclusive: Cytosorbents CEO On How Its Blood Purification Technology Can Change Healthcare
Monday, August 15, 2016 - 8:54am | 611Read More...Cytosorbents Corp (NASDAQ: CTSO) is a critical care focused immunotherapy company that focuses on the commercializing its main product, CytoSorb - a blood purification technology which focuses on preventing or treating multiple organ failures. Benzinga had the opportunity to chat with the...
-
Cytosorbents Gains 10% Following Encouraging Top Line Results
Friday, February 26, 2016 - 2:58pm | 244Read More...Shares of Cytosorbents Corp (NASDAQ: CTSO) gained more than 10 percent on Friday after the company presented data from its first CytoSorb investigator-initiated septic shock study at an industry conference in Germany. According to the company's press release, "All patients had...
